A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas

Leah V. Steyn, Kameswari Ananthakrishnan, Miranda J. Anderson, Renata Patek, Amy Kelly, Josef Vagner, Ronald M. Lynch, Sean W. Limesand

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas'. Together they form a unique fingerprint.

Medicine & Life Sciences